Company sells 751,500 units with half-share warrants at $2.00 each
By Devika Patel
Knoxville, Tenn., Dec. 5 - Morria Biopharmaceuticals plc settled a $1.5 million private placement of units on Nov. 30, according to a 6-K filed Wednesday with the Securities and Exchange Commission.
The company sold 751,500 units of one ordinary share and one half-share warrant at $2.00 per unit. Each whole warrant is exercisable at $2.00 for five years.
The private drug development company is based in London.
| Issuer: | Morria Biopharmaceuticals plc
|
| Issue: | Units of one ordinary share and one half-share warrant
|
| Amount: | $1,503,000
|
| Units: | 751,500
|
| Price: | $2.00
|
| Warrants: | One half-share warrant per unit
|
| Warrant expiration: | Five years
|
| Warrant strike price: | $2.00
|
| Settlement date: | Nov. 30
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
